Pfizer's Accupril no help after bypass surgery
5th Sep 2005, 17:27 GMT
STOCKHOLM (Reuters) - Giving Pfizer Inc.'s drug Accupril to patients who have recently had bypass surgery provides no benefit, researchers said on Monday.
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study